← Human Trials & Peer-Reviewed Studies
Effects of growth hormone on anthropometric measurements and cardiac function in children with thermal injury.
Plain-language guide to PMID 15639367 (2005): double-blind randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
Key Facts
- PMID
- 15639367
- Journal
- Burns : journal of the International Society for Burn Injuries
- Year
- 2005
- Study type
- Randomized Controlled Trial
- Authors
- Mlcak RP et al. (4 authors)
- DOI
- 10.1016/j.burns.2004.08.006
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
Outcome variables included height, weight, lean body mass, resting energy expenditure, cardiac index, stroke-volume index, heart rate and left ventricular ejection fraction.
Who Took Part
By PubMed's age tags, the people studied were infants, young children, children and teenagers, both men and women.
How the Study Was Run
In design terms this was a randomized, double-blind and placebo-controlled study.
The participants were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.
As a double-blind Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study, the assignments were hidden from both participants and investigators until the end.
The comparison arm used a placebo, so changes seen with Exogenous HGH, sermorelin & older GHRPs (why they're passed over) could be set against what happens without it.
What Was Measured
Outcome variables included height, weight, lean body mass, resting energy expenditure, cardiac index, stroke-volume index, heart rate and left ventricular ejection fraction.
The subject headings attached to it are Body Height, Burns, Energy Metabolism, Heart, Heart Rate, Human Growth Hormone and Stroke Volume.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).
Its findings take up roughly 2 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2005 (Burns : journal of the International Society for Burn Injuries), a journal based in Netherlands.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.
Our Notes on the Compound
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.